Latest releases
Nov 21, 2014:
Lytix Biopharma appoints Andrew Saunders, M.D., FFPM as Chief Medical Officer
Nov 10, 2014:
Lytix Biopharma attended SITC in Washington Nov 6-9, 2014
Oct 31, 2014:
‘New star’ – Lytix Biopharma recognized in Aftenposten
Oct 29, 2014:
New article about LTX-109 published in ‘Antimicrobial Agents and Chemotherapy’